Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial

Eileen P. Scully, Evgenia Aga, Athe Tsibris, Nancie Archin, Kate Starr, Qing Ma, Gene D. Morse, Kathleen E. Squires, Bonnie J. Howell, Guoxin Wu, Lara Hosey, Scott F. Sieg, Lynsay Ehui, Francoise Giguel, Kendyll Coxen, Curtis Dobrowolski, Monica Gandhi, Steve Deeks, Nicolas Chomont, Elizabeth ConnickCatherine Godfrey, Jonathan Karn, Daniel R. Kuritzkes, Ronald J. Bosch, Rajesh T. Gandhi

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences